
Pacira Biosciences Inc
NASDAQ:PCRX

Intrinsic Value
The intrinsic value of one
PCRX
stock under the Base Case scenario is
61.94
USD.
Compared to the current market price of 25.24 USD,
Pacira Biosciences Inc
is
Undervalued by 59%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Pacira Biosciences Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Pacira Biosciences Inc
Balance Sheet Decomposition
Pacira Biosciences Inc
Current Assets | 745.1m |
Cash & Short-Term Investments | 484.6m |
Receivables | 113.3m |
Other Current Assets | 147.2m |
Non-Current Assets | 808.4m |
Long-Term Investments | 35.6m |
PP&E | 216.4m |
Intangibles | 426m |
Other Non-Current Assets | 130.4m |
Free Cash Flow Analysis
Pacira Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Pacira Biosciences Inc
Revenue
|
701m
USD
|
Cost of Revenue
|
-170.4m
USD
|
Gross Profit
|
530.5m
USD
|
Operating Expenses
|
-433m
USD
|
Operating Income
|
97.6m
USD
|
Other Expenses
|
-197.1m
USD
|
Net Income
|
-99.6m
USD
|
PCRX Profitability Score
Profitability Due Diligence
Pacira Biosciences Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
Pacira Biosciences Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
PCRX Solvency Score
Solvency Due Diligence
Pacira Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Pacira Biosciences Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
PCRX
is 39.78 USD
with a low forecast of 26.26 USD and a high forecast of 68.25 USD.
Dividends
Current shareholder yield for PCRX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PCRX
stock under the Base Case scenario is
61.94
USD.
Compared to the current market price of 25.24 USD,
Pacira Biosciences Inc
is
Undervalued by 59%.